These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3879960)

  • 21. In vitro cytotoxicity of a human serum albumin-mediated conjugate of methotrexate with anti-MM46 monoclonal antibody.
    Endo N; Kato Y; Takeda Y; Saito M; Umemoto N; Kishida K; Hara T
    Cancer Res; 1987 Feb; 47(4):1076-80. PubMed ID: 3802092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regiospecific gamma-conjugation of methotrexate to poly(L-lysine). Chemical and biological studies.
    Rosowsky A; Forsch RA; Galivan J; Susten SS; Freisheim JH
    Mol Pharmacol; 1985 Jan; 27(1):141-7. PubMed ID: 3965926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
    Rhee MS; Galivan J; Wright JE; Rosowsky A
    Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase.
    Jackman AL; Kimbell R; Aherne GW; Brunton L; Jansen G; Stephens TC; Smith MN; Wardleworth JM; Boyle FT
    Clin Cancer Res; 1997 Jun; 3(6):911-21. PubMed ID: 9815766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V; Ritz J; Basala M; Schlossman SF
    Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conjugation of methotrexate to immunoglobulins kills macrophages by Fc receptor mediated uptake?
    Wang X; Yao C; Jiang Z
    Int J Lab Hematol; 2008 Jun; 30(3):185-90. PubMed ID: 18479295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a dual label fluorescence technique that can be utilized to elucidate the mechanism of action of monoclonal antibody-drug conjugates.
    Starling JJ; Hinson NA; Marder P; Maciak RS; Laguzza BC; Corvalan JR; Smith W
    Cancer Res; 1988 Nov; 48(21):6211-6. PubMed ID: 3048656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.
    Weigand M; Hartung G; Roboz J; Sieger S; Wolf M; Sinn H; Schrenk HH; Wiessler M; Frei E
    Anticancer Drug Des; 2001; 16(4-5):227-37. PubMed ID: 12049481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific in vitro anti-tumour activity of methotrexate-monoclonal antibody conjugates prepared using human serum albumin as an intermediary.
    Pietersz GA; Cunningham Z; McKenzie IF
    Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():43-9. PubMed ID: 3372005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigenicity and drug susceptibility of human osteogenic sarcoma cells "escaping" a cytotoxic methotrexate-albumin-monoclonal antibody conjugate.
    Embleton MJ; Garnett MC; Jacobs E; Baldwin RW
    Br J Cancer; 1984 May; 49(5):559-65. PubMed ID: 6586198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor activity of antifolate inhibitors of thymidylate and purine synthesis in human soft tissue sarcoma cell lines with intrinsic resistance to methotrexate.
    Li WW; Tong WP; Bertino JR
    Clin Cancer Res; 1995 Jun; 1(6):631-6. PubMed ID: 9816025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and in vitro testing of methotrexate carrier conjugates linked via oligopeptide spacers.
    Fitzpatrick JJ; Garnett MC
    Anticancer Drug Des; 1995 Jan; 10(1):1-9. PubMed ID: 7695810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxicities of two disulfide-bond-linked conjugates of methotrexate with monoclonal anti-MM46 antibody.
    Umemoto N; Kato Y; Hara T
    Cancer Immunol Immunother; 1989; 28(1):9-16. PubMed ID: 2783302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymidylate synthase as a target for growth inhibition in methotrexate-sensitive and -resistant human head and neck cancer and leukemia cell lines.
    McGuire JJ; Magee KJ; Russell CA; Canestrari JM
    Oncol Res; 1997; 9(3):139-47. PubMed ID: 9220499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective antitumor effect on L10 hepatocarcinoma cells of a potent immunoconjugate composed of the A chain of abrin and a monoclonal antibody to a hepatoma-associated antigen.
    Hwang KM; Foon KA; Cheung PH; Pearson JW; Oldham RK
    Cancer Res; 1984 Oct; 44(10):4578-86. PubMed ID: 6467213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Target-selective cytotoxicity of methotrexate conjugated with monoclonal anti-MM46 antibody.
    Endo N; Takeda Y; Kishida K; Kato Y; Saito M; Umemoto N; Hara T
    Cancer Immunol Immunother; 1987; 25(1):1-6. PubMed ID: 3496155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and characterization of methotrexate-immunoglobulin conjugates.
    Ghosh MK; Kildsig DO; Mitra AK
    Drug Des Deliv; 1989 Jan; 4(1):13-25. PubMed ID: 2789065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity of multidrug-resistant MCF-7 cells to a transferrin-doxorubicin conjugate.
    Lemieux P; Pagé M
    Anticancer Res; 1994; 14(2A):397-403. PubMed ID: 8017839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
    Hartung G; Stehle G; Sinn H; Wunder A; Schrenk HH; Heeger S; Kränzle M; Edler L; Frei E; Fiebig HH; Heene DL; Maier-Borst W; Queisser W
    Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.